Endpoints 11: Biopharma's most promising startups in 2026

A fireside with Donald Ingber
on a night built for real conversation

On Sept. 24, Endpoints News names the 2026 Endpoints 11 live in Boston. In one night, you meet the founders building these companies, the scientists behind the work and the investors backing them.

Just announced: Join us for a fireside chat with Donald Ingber, founding director of the Wyss Institute and a pioneer of Organ Chip technology. He'll assess the state of discovery and innovation — and where this year's list fits in.

Donald Ingber, MD, PhD Founding director and core faculty member, Wyss Institute for Biologically Inspired Engineering at Harvard University

Reserve your seat and save $100 with early bird

Can’t make it to the event? Get your virtual pass.

It's an intentionally intimate evening, built for real conversation rather than a panel and a name badge. Come for the reveal. Stay for the people you'll be glad you met.

Reserve your seat and save $100 with early bird

Can’t make it to the event? Get your virtual pass.

A fireside with Donald Ingber on a night built for real conversation

A fireside with Donald Ingber
on a night built for real conversation